Advanced Biomed Inc. (ADVB)

Market Cap	3.80M -61.4%
Revenue (ttm)	127,637
Net Income	6.68M
EPS	5.33
Shares Out	1.65M
PE Ratio	0.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,779
Open	2.815
Previous Close	2.640
Day's Range	2.250 - 2.815
52-Week Range	2.250 - 24.229
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 18, 2026

About ADVB

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of ca...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Mar 6, 2025
• Employees: 12
• Stock Exchange: Nasdaq
• Ticker Symbol: ADVB
• Website: https://www.advb.ai

Financial Performance

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 31, 2026

Data Sources Report a data error